Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

[New psychotropic drugs - "legal highs"].

Scherbaum N, Schifano F, Siemann H.

Fortschr Neurol Psychiatr. 2014 Sep;82(9):532-43; quiz 543-4. doi: 10.1055/s-0034-1384916. Epub 2014 Sep 1. German. No abstract available.

PMID:
25177905
[PubMed - in process]
2.

Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: Cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.

Bonnet U, Specka M, Stratmann U, Ochwadt R, Scherbaum N.

Drug Alcohol Depend. 2014 Oct 1;143:189-97. doi: 10.1016/j.drugalcdep.2014.07.027. Epub 2014 Aug 1.

PMID:
25127704
[PubMed - in process]
3.

XRCC5 as a Risk Gene for Alcohol Dependence: Evidence from a Genome-Wide Gene-Set-Based Analysis and Follow-up Studies in Drosophila and Humans.

Juraeva D, Treutlein J, Scholz H, Frank J, Degenhardt F, Cichon S, Ridinger M, Mattheisen M, Witt SH, Lang M, Sommer WH, Hoffmann P, Herms S, Wodarz N, Soyka M, Zill P, Maier W, Jünger E, Gaebel W, Dahmen N, Scherbaum N, Schmäl C, Steffens M, Lucae S, Ising M, Smolka MN, Zimmermann US, Müller-Myhsok B, Nöthen MM, Mann K, Kiefer F, Spanagel R, Brors B, Rietschel M.

Neuropsychopharmacology. 2014 Jul 18. doi: 10.1038/npp.2014.178. [Epub ahead of print]

PMID:
25035082
[PubMed - as supplied by publisher]
4.

Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling.

Sowa JP, Atmaca Ö, Kahraman A, Schlattjan M, Lindner M, Sydor S, Scherbaum N, Lackner K, Gerken G, Heider D, Arteel GE, Erim Y, Canbay A.

PLoS One. 2014 Jul 2;9(7):e101444. doi: 10.1371/journal.pone.0101444. eCollection 2014.

PMID:
24988316
[PubMed - in process]
Free PMC Article
5.

KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.

Thoens C, Berger C, Trippler M, Siemann H, Lutterbeck M, Broering R, Schlaak J, Heinemann FM, Heinold A, Nattermann J, Scherbaum N, Alter G, Timm J.

J Hepatol. 2014 Sep;61(3):475-81. doi: 10.1016/j.jhep.2014.04.020. Epub 2014 Apr 26.

PMID:
24780303
[PubMed - in process]
6.

Can reinforcement-based interventions to reduce drug use successfully be adapted to routine opioid maintenance treatment?

Specka M, Böning A, Kluwig J, Schifano F, Banger M, Lange W, Lax H, Marrziniak B, Schüngel C, Scherbaum N.

Ann Ist Super Sanita. 2013;49(4):358-64. doi: DOI: 10.4415/ANN_13_04_07.

PMID:
24334780
[PubMed - in process]
Free Article
7.

[Outcomes of Comprehensive Inpatient Opiate Detoxification in Patients Re-Admitted to Treatment Within One Year.]

Specka M, Lopez Gonzales K, Scherbaum N.

Psychiatr Prax. 2013 Nov 19. [Epub ahead of print] German.

PMID:
24254425
[PubMed - as supplied by publisher]
8.

Attenuated Readiness Potential in the Absence of Executive Dysfunction in Adults With ADHD.

Seo BK, Sartory G, Kis B, Scherbaum N, Müller BW.

J Atten Disord. 2013 Oct 25. [Epub ahead of print]

PMID:
24163327
[PubMed - as supplied by publisher]
9.

Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.

Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.

PMID:
23884073
[PubMed - indexed for MEDLINE]
Free Article
10.

Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project.

Corazza O, Assi S, Simonato P, Corkery J, Bersani FS, Demetrovics Z, Stair J, Fergus S, Pezzolesi C, Pasinetti M, Deluca P, Drummond C, Davey Z, Blaszko U, Moskalewicz J, Mervo B, Furia LD, Farre M, Flesland L, Pisarska A, Shapiro H, Siemann H, Skutle A, Sferrazza E, Torrens M, Sambola F, van der Kreeft P, Scherbaum N, Schifano F.

Hum Psychopharmacol. 2013 Jul;28(4):317-23. doi: 10.1002/hup.2299.

PMID:
23881879
[PubMed - indexed for MEDLINE]
11.

Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.

Radbruch L, Glaeske G, Grond S, Münchberg F, Scherbaum N, Storz E, Tholen K, Zagermann-Muncke P, Zieglgänsberger W, Hoffmann-Menzel H, Greve H, Cremer-Schaeffer P.

Subst Abus. 2013;34(3):313-20. doi: 10.1080/08897077.2012.735216. Review.

PMID:
23844964
[PubMed - indexed for MEDLINE]
12.

[Opiate dependency].

Scherbaum N, Lieb B.

Fortschr Neurol Psychiatr. 2013 Jun;81(6):346-57; quiz 358. doi: 10.1055/s-0033-1335646. Epub 2013 Jun 17. Review. German. No abstract available.

PMID:
23775167
[PubMed - indexed for MEDLINE]
13.

αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior.

Easton AC, Lucchesi W, Lourdusamy A, Lenz B, Solati J, Golub Y, Lewczuk P, Fernandes C, Desrivieres S, Dawirs RR, Moll GH, Kornhuber J, Frank J, Hoffmann P, Soyka M, Kiefer F; GESGA Consortium, Schumann G, Peter Giese K, Müller CP, Treutlein J, Cichon S, Ridinger M, Mattheisen P, Herms S, Wodarz N, Zill P, Maier W, Mössner R, Gaebel W, Dahmen N, Scherbaum N, Schmäl C, Steffens M, Lucae S, Ising M, Müller-Myhsok B, Nöthen MM, Mann K, Rietschel M.

Neuropsychopharmacology. 2013 Aug;38(9):1636-47. doi: 10.1038/npp.2013.60. Epub 2013 Mar 4. Erratum in: Neuropsychopharmacology. 2013 Dec;38(13):2735.

PMID:
23459588
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex.

Bauer J, Pedersen A, Scherbaum N, Bening J, Patschke J, Kugel H, Heindel W, Arolt V, Ohrmann P.

Neuropsychopharmacology. 2013 Jul;38(8):1401-8. doi: 10.1038/npp.2013.45. Epub 2013 Feb 12.

PMID:
23403696
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care.

Apelt SM, Scherbaum N, Gölz J, Backmund M, Soyka M.

Pharmacopsychiatry. 2013 May;46(3):94-107. doi: 10.1055/s-0032-1330033. Epub 2013 Jan 4.

PMID:
23293011
[PubMed - indexed for MEDLINE]
16.

Structural brain alterations associated with schizophrenia preceded by conduct disorder: a common and distinct subtype of schizophrenia?

Schiffer B, Leygraf N, Müller BW, Scherbaum N, Forsting M, Wiltfang J, Gizewski ER, Hodgins S.

Schizophr Bull. 2013 Sep;39(5):1115-28. doi: 10.1093/schbul/sbs115. Epub 2012 Sep 26.

PMID:
23015687
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Craving dominates propofol addiction of an affected physician.

Bonnet U, Scherbaum N.

J Psychoactive Drugs. 2012 Apr-Jun;44(2):186-90.

PMID:
22880547
[PubMed - indexed for MEDLINE]
18.

Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project.

Deluca P, Davey Z, Corazza O, Di Furia L, Farre M, Flesland LH, Mannonen M, Majava A, Peltoniemi T, Pasinetti M, Pezzolesi C, Scherbaum N, Siemann H, Skutle A, Torrens M, van der Kreeft P, Iversen E, Schifano F.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):221-6. doi: 10.1016/j.pnpbp.2012.07.011. Epub 2012 Jul 27.

PMID:
22841965
[PubMed - indexed for MEDLINE]
19.

Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.

Schlaak JF, Trippler M, Hoyo-Becerra C, Erim Y, Kis B, Wang B, Scherbaum N, Gerken G.

PLoS One. 2012;7(6):e38668. doi: 10.1371/journal.pone.0038668. Epub 2012 Jun 6.

PMID:
22701688
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4+CD25(high) regulatory T cell frequencies in heroin user.

Riss GL, Chang DI, Wevers C, Westendorf AM, Buer J, Scherbaum N, Hansen W.

Brain Behav Immun. 2012 Aug;26(6):972-8. doi: 10.1016/j.bbi.2012.05.008. Epub 2012 May 18.

PMID:
22613171
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk